Extracellular matrix 1 (ECM1) expression is a novel prognostic marker for poor long-term survival in breast cancer: A hospital-based cohort study in Iowa

Annals of Surgical Oncology

Volumn 16, Issue 8, 2009, Pages 2280-2287

  Lal, Geeta ^a   Hashimi, Samad ^a   Smith, Brian J ^b   Lynch, Charles F ^a,b   Zhang, Lurong ^c   Robinson, Robert A ^a   Weigel, Ronald J ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; SCLEROPROTEIN; SCLEROPROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PROGNOSIS; UNITED STATES;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; COHORT STUDIES; COMBINED MODALITY THERAPY; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 67650986131     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0533-2     Document Type: Article

References (35)

1. www.seer.cancer.gov.
2. Proceedings of the 9th International Conference on Primary Therapy of Early Breast Cancer. 26-29 January 2005. St. Gallen, Switzerland. Breast. 2005;14:427-642.
3. Early Breast Cancer Trialists' Collaborative Group 1998 Tamoxifen for early breast cancer: an overview of the randomised trials Lancet 351 1451 1467
4. LK Diaz N Sneige 2005 Estrogen receptor analysis for breast cancer: current issues and keys to increasing testing accuracy Adv Anat Pathol 12 10 19
5. MJ Duffy 2005 Predictive markers in breast and other cancers: a review Clin Chem 51 494 503
6. CL Vogel MA Cobleigh D Tripathy 2002 Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer J Clin Oncol 20 719 726
7. EH Romond EA Perez J Bryant 2005 Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer N Engl J Med 353 1673 1684
8. VC Jordan MF Wolf DM Mirecki DA Whitford WV Welshons 1988 Hormone receptor assays: clinical usefulness in the management of carcinoma of the breast Crit Rev Clin Lab Sci 26 97 152
9. MR Johnson DJ Wilkin HL Vos RI Ortiz de Luna AM Dehejia MH Polymeropoulos CA Francomano 1997 Characterization of the human extracellular matrix protein 1 gene on chromosome 1q21 Matrix Biol 16 289 292
10. P Smits J Ni P Feng J Wauters W Van Hul ME Boutaibi 1997 The human extracellular matrix gene 1 (ECM1): genomic structure, cDNA cloning, expression pattern, and chromosomal localization Genomics 45 487 495
11. P Smits Y Poumay M Karperien 2000 Differentiation-dependent alternative splicing and expression of the extracellular matrix protein 1 gene in human keratinocytes J Invest Dermatol 114 718 724
12. S Sercu L Zhang J Merregaert 2008 The extracellular matrix protein 1: its molecular interaction and implication in tumor progression Cancer Invest 26 375 384
13. T Hamada WH McLean M Ramsay 2002 Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1) Hum Mol Genet 11 833 840
14. Z Han J Ni P Smits 2001 Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells Faseb J 15 988 994
15. Lal G, Padmanabha L, Nicholson R, et al. ECM1 expression in thyroid tumors-a comparison of real-time RT-PCR and IHC. J Surg Res. 2007.
16. E Kebebew M Peng E Reiff QY Duh OH Clark A McMillan 2005 ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy Ann Surg 242 353 363
17. E Kebebew M Peng E Reiff A McMillan 2006 Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms Cancer 106 2592 2597
18. L Wang J Yu J Ni 2003 Extracellular matrix protein 1 (ECM1) is overexpressed in malignant epithelial tumors Cancer Lett 200 57 67
19. M Nessling K Richter C Schwaenen 2005 Candidate genes in breast cancer revealed by microarray-based comparative genomic hybridization of archived tissue Cancer Res 65 439 447
20. LA McPherson GW Woodfield RJ Weigel 2007 AP2 transcription factors regulate expression of CRABPII in hormone responsive breast carcinoma J Surg Res 138 71 78
21. AM Brewster GN Hortobagyi KR Broglio 2008 Residual risk of breast cancer recurrence 5 years after adjuvant therapy J Natl Cancer Inst 100 1179 1183
22. G Pawlak DM Helfman 2001 Cytoskeletal changes in cell transformation and tumorigenesis Curr Opin Genet Dev 11 41 47
23. BC Turner J Zhang AA Gumbs 1998 Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways Cancer Res 58 5466 5472
24. J Pellikainen A Naukkarinen K Ropponen 2004 Expression of HER2 and its association with AP-2 in breast cancer Eur J Cancer 40 1485 1495
25. JM Bosher NF Totty JJ Hsuan T Williams HC Hurst 1996 A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma Oncogene 13 1701 1707
26. JM Bosher T Williams HC Hurst 1995 The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma Proc Natl Acad Sci USA 92 744 747
27. Y Wang JG Klijn Y Zhang 2005 Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Lancet 365 671 679
28. C Sotiriou P Wirapati S Loi 2006 Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis J Natl Cancer Inst 98 262 272
29. http://www.oncomine.org/.
30. A Bergamaschi E Tagliabue T Sorlie 2008 Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome J Pathol 214 357 367
31. T Sorlie CM Perou R Tibshirani 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 10869 10874
32. CM Perou T Sorlie MB Eisen 2000 Molecular portraits of human breast tumours Nature 406 747 752
33. MJ van de Vijver YD He LJ van't Veer 2002 A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 347 1999 2009
34. S Paik S Shak G Tang 2004 A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 2817 2826
35. S Paik G Tang S Shak 2006 Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer J Clin Oncol 24 3726 3734